phosphoserine and ng-nitroarginine methyl ester

phosphoserine has been researched along with ng-nitroarginine methyl ester in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bruckdorfer, KR; Friebe, A; Koesling, D; Naseem, KM; Sabetkar, M; Tullett, JM1
Butcher, SP; Macleod, MR1
Boekstegers, P; Bouzin, C; Daneau, G; Dessy, C; Feron, O; Hinkel, R; Kupatt, C; Raake, P1
Clergue, M; Condorelli, G; Desortes, E; Emanueli, C; Figueroa, CD; Gadau, S; Madeddu, P; Meloni, M; Salis, MB; Silvestre, JS; Van Linthout, S1

Other Studies

4 other study(ies) available for phosphoserine and ng-nitroarginine methyl ester

ArticleYear
Synergism between nitric oxide and hydrogen peroxide in the inhibition of platelet function: the roles of soluble guanylyl cyclase and vasodilator-stimulated phosphoprotein.
    Nitric oxide : biology and chemistry, 2001, Volume: 5, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; Alkaloids; Blood Platelets; Blood Proteins; Carbazoles; Cell Adhesion Molecules; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cytosol; Drug Synergism; Enzyme Inhibitors; Guanylate Cyclase; Humans; Hydrazines; Hydrogen Peroxide; In Vitro Techniques; Indazoles; Indoles; Kinetics; Microfilament Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitrogen Oxides; Phosphoproteins; Phosphoserine; Platelet Aggregation; Platelet Aggregation Inhibitors; Subcellular Fractions; Thrombin

2001
Nitric-oxide-synthase-mediated cyclic guanosine monophosphate production in neonatal rat cerebellar prisms is resistant to calcineurin inhibition.
    Neuroscience letters, 2002, Mar-29, Volume: 322, Issue:1

    Topics: Animals; Animals, Newborn; Brain Ischemia; Calcineurin; Calcineurin Inhibitors; Cerebellum; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Female; Immunosuppressive Agents; Male; N-Methylaspartate; Neurons; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phosphorylation; Phosphoserine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Tacrolimus

2002
Heat shock protein 90 transfection reduces ischemia-reperfusion-induced myocardial dysfunction via reciprocal endothelial NO synthase serine 1177 phosphorylation and threonine 495 dephosphorylation.
    Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:8

    Topics: Animals; Benzoquinones; Calcineurin; Coronary Vessels; Cyclic GMP; Endothelium, Vascular; Enzyme Inhibitors; Genetic Therapy; Genetic Vectors; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Liposomes; Myocardial Infarction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phosphorylation; Phosphoserine; Phosphothreonine; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Quinones; Sus scrofa; Transfection; Umbilical Veins; Vascular Endothelial Growth Factor A

2004
Akt/protein kinase B and endothelial nitric oxide synthase mediate muscular neovascularization induced by tissue kallikrein gene transfer.
    Circulation, 2004, Sep-21, Volume: 110, Issue:12

    Topics: Adenoviridae; Animals; Blotting, Western; Cell Division; Endothelial Cells; Endothelium, Vascular; Enzyme Induction; Exudates and Transudates; Genes, Dominant; Genetic Vectors; Humans; Mice; Microcirculation; Muscle, Skeletal; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phosphorylation; Phosphoserine; Polymerase Chain Reaction; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; RNA, Messenger; Tissue Kallikreins; Transduction, Genetic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2004